Full Text (PDF)
Review Article

Contribution of Dr. Rita Levi Montalcini in Field of Paediatrics

Manisha Mohan Naidu, Kasumbiwal Ajay H, Dake Mangesh, Tambe Pranita

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Pediatric Education and Research 13(2):p 370-373, July-Dec 2025. | DOI: 10.21088/per.2321.1644.13225.86

How Cite This Article:

Kasumbiwal Ajay H., Dake Mangesh V., Tambe Pranita, et al. Contribution of Dr. Rita Levi Montalcini in Field of Paediatrics. Pediatr. Edu. Res. 2025; 13(2): 370-373.

Timeline

Received : December 10, 2025         Accepted : December 22, 2025          Published : December 30, 2025

Abstract

Rita Levi-Montalcini was a pioneering neuroscientist whose discovery of nerve growth factor (NGF) profoundly influenced modern neuroscience and pediatric medicine. Her work provided crucial insights into the mechanisms of neuronal growth, differentiation, and survival, which have significant implications for child health and neurodevelopmental disorders. This article highlights the life, scientific contributions, challenges, and lasting legacy of Dr. Rita Levi-Montalcini with a special focus on pediatrics. NGF, discovered by Levi-Montalcini, plays a vital role in the development and maintenance of the nervous system during infancy and childhood. It has been shown to influence neuronal maturation, synaptic plasticity, and regeneration, making it particularly relevant in pediatric neurological conditions such as congenital neuropathies, cerebral palsy, neurodevelopmental delay, and perinatal brain injury.1–3 Beyond the nervous system, NGF has also been implicated in immune regulation and tissue repair, opening new therapeutic possibilities in pediatric inflammatory and genetic disorders.4,5 Despite facing significant obstacles including gender discrimination and racial persecution during World War II, Levi-Montalcini continued her research under extremely challenging circumstances, demonstrating remarkable perseverance and dedication to science.6 Her achievements were recognized with the Nobel Prize in Physiology or Medicine in 1986, inspiring generations of researchers and clinicians worldwide.7 In pediatrics, her work laid the foundation for translational research targeting neuroprotection, neuroregeneration, and early intervention strategies in childhood neurological disorders.8–10 Dr. Rita Levi-Montalcini’s scientific legacy continues to shape pediatric neuroscience, emphasizing the importance of fundamental research in improving child health outcomes Key Message: The discovery of NGF revolutionised concepts of neuronal growth and survival and opened new approaches to paediatric neurological disorders, showing how perseverance and innovative thinking can advance science and clinical practice.


References

No records found.


About this article


Cite this article

Kasumbiwal Ajay H., Dake Mangesh V., Tambe Pranita, et al. Contribution of Dr. Rita Levi Montalcini in Field of Paediatrics. Pediatr. Edu. Res. 2025; 13(2): 370-373.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
December 10, 2025 December 22, 2025 December 30, 2025

DOI: 10.21088/per.2321.1644.13225.86

Keywords

• Rita Levi-Montalcini• Nerve Growth Factor• NGFPaediatric neuroscience• Neuron development• Neurotrophins• Women in science• Neurodevelopmental disorders• Neurodegeneration

Article Level Metrics

Last Updated

Wednesday 24 June 2026, 12:39:40 (IST)


645

Accesses

2
110
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received December 10, 2025
Accepted December 22, 2025
Published December 30, 2025

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share